Live from the NIH registry
Studies recruiting near Palmdale right now
Top 25 of 124 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Medvin Clinical Research - Tujunga — Tujunga, California (25.8 mi)
· Sponsor: Crystalys Therapeutics
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Diabetes Mellitus, Type 2
Phase 2
Interventional 270 participants sought
First Valley Medical Group — Lancaster, California (7.4 mi)
· Sponsor: Novo Nordisk A/S
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 140 participants sought
Om Research, LLC — Lancaster, California (7.4 mi)
· Sponsor: Eli Lilly and Company
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Intracerebral Hemorrhage, Stroke
N/A
Observational 1,018 participants sought
Antelope Valley Medical Center — Lancaster, California (7.4 mi)
· Sponsor: Zeenat Qureshi Stroke Institute
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 425 participants sought
Om Research LLC — Lancaster, California (7.4 mi)
· Sponsor: Hoffmann-La Roche
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Brain Metastases
Phase 3
Interventional 206 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: Canadian Cancer Trials Group
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 4
Interventional 350 participants sought
GSK Investigational Site — Tujunga, California (25.8 mi)
· Sponsor: GlaxoSmithKline
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: NRG Oncology
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Alopecia Areata
Phase 2
Interventional 60 participants sought
Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway — Santa Clarita, California (28.6 mi)
· Sponsor: Eli Lilly and Company
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Crohn's Disease
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400001 — Lancaster, California (7.4 mi)
· Sponsor: Sanofi
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: Canadian Cancer Trials Group
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Focal Seizure, Epilepsy
Phase 3
Interventional 333 participants sought
Amicis Research Center — Palmdale, California (1.2 mi)
· Sponsor: Rapport Therapeutics Inc.
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
USC Norris Santa Clarita Oncology — Santa Clarita, California (28.6 mi)
· Sponsor: NRG Oncology
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Lancaster, California (7.4 mi)
· Sponsor: Akero Therapeutics, Inc
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
Amicis Research Center, LLC- Site Number : 8400110 — Palmdale, California (1.2 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Chronic Migraine
Phase 3
Interventional 780 participants sought
Chemidox Clinical Trials Inc, Merz Investigational Site #0010488 — Lancaster, California (7.4 mi)
· Sponsor: Merz Therapeutics GmbH
Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference
Colonic Polyps
N/A
Interventional 330 participants sought
Gastro Care Institute — Lancaster, California (7.4 mi)
· Sponsor: Capso Vision, Inc.
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: National Cancer Institute (NCI)
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 1,000 participants sought
Local Institution - 1142 — Lancaster, California (7.4 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
Chagas Disease
Phase 2
Interventional 130 participants sought
Olive View UCLA Educ and Res Ins — Sylmar, California (27.8 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
Irritable Bowel Syndrome, Constipation
Phase 2
Interventional 342 participants sought
Om Research LLC — Lancaster, California (7.4 mi)
· Sponsor: Eli Lilly and Company
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Om Research LLC — Lancaster, California (7.4 mi)
· Sponsor: Ardelyx
Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers
Metastatic Pancreatic Adenocarcinoma
N/A
Interventional 136 participants sought
City of Hope at Palmdale — Palmdale, California (1.2 mi)
· Sponsor: City of Hope Medical Center